Minimal clinically important difference

The minimal clinically important difference, or MCID, is the smallest change on a symptom scale that a patient would actually notice and consider meaningful.

This term is specific to research interpretation and is defined on AnxietyResearch. Shrinktionary, the network's language layer, doesn't currently carry a canonical entry for it.

Symptom scales turn how a person feels into a number. Not every change in that number matters. The MCID is the threshold where a change becomes large enough to feel real. A change below the MCID may be statistically detectable yet too small to matter in daily life.

The MCID is the tool that connects a trial result to a patient's experience. It is how you tell whether a significant improvement is also a meaningful one. For the GAD-7, a common anxiety scale, research points to a change of roughly 4 points as the rough mark of a noticeable improvement.

A trial reports that a treatment improved GAD-7 scores by 2 points more than placebo. That's below the rough 4-point mark, so the average patient might not notice the extra benefit, even if the result is statistically significant.

The MCID is an estimate, not a hard line, and it differs by scale and by study. Still, it's one of the best questions to ask of any trial: did the treatment beat placebo by enough to matter, not just by enough to reach statistical significance.